FindTrial
Sign In

Level of Endocan in patient with heart attack

Evaluation of serum endocan level in patients with myocardial infarction - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/074448
Enrollment
46
Registered
2024-09-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I219- Acute myocardial infarction, unspecified

Interventions

Intervention1: NIL: NIL

Sponsors

Kasturba Medical College, Manipal, MAHE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Troponin T more than 0.02 ng/mL and less than 0.02 ng/mL

Exclusion criteria

Exclusion criteria: Acute renal disease/CKD Poisoning cases Trauma cases Pregnant women

Design outcomes

Primary

MeasureTime frame
Biomarker confirms the occurrence of endothelial injury earlier along with the lipid profile and might help to predict the occurrence of CAD development and its progression in the future populations.Timepoint: 6 weeks after receiving approval—

Secondary

MeasureTime frame
Early identification of the risk of MI & PublicationTimepoint: 14 weeks after initiating the sample collection—

Countries

India

Contacts

Public ContactChaithra Kamath

Kasturba Medical College, Manipal

vaideki.b@manipal.edu9842112419

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026